The defective MMR protein expression in tumor tissue can be attributable to germline or somatic mutation in another DNA repair or replication-associated gene, such as BRAF, POLE/POLD1, or less frequently, MUTYH [21, 22]. This evidence concerns the gene POLE and neoplasm.